Pharmaceutical company AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion that will speed up its entry into the commercial market for ovarian cancer
Abbvie to acquire Waltham cancer firm and its drug for $10B
wbjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbjournal.com Daily Mail and Mail on Sunday newspapers.
Pharmaceutical company AbbVie buying ImmunoGen in $10 1 billion deal
sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.
Pharmaceutical company AbbVie buying ImmunoGen in $10 1 billion deal
tribtown.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribtown.com Daily Mail and Mail on Sunday newspapers.
Pharmaceutical company AbbVie buying ImmunoGen in $10 1 billion deal
chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.